Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note indicating enrollment is closed; the Intervention/Treatment heading formatting was normalized and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check17 days agoChange DetectedThe page shows a revision indicator updated from v3.5.4 to v3.5.5, signaling a minor software release rather than a content change.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was removed, indicating an internal update to the page's template/versioning. There are no changes described to displayed study information.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor update to the page's versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.